New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...

As the demand for proactive lifestyle management continues to gain national momentum, Boston Vitality, a premier wellness ...

Vertex Pharmaceuticals (VRTX) announced data from a Phase 4 study of JOURNAVX, a prescription non-opioid pain signal inhibitor for the treatment of moderate-to-severe acute pain, in adults, that ...

Q4 2025 earnings call: data incident fallout, revenue/EBITDA trends, Q1 guidance, and Taiwan growth outlook—read the key insights now.

As cyber risks and operational demands increase, local organizations seek stable, scalable IT support to protect ...

Health Recovery Solutions acquires Rimidi to enhance its remote care platform with advanced chronic disease management and EHR integration.

Binance secures ISO 22301 certification, confirming strong business continuity systems and digital operational resilience.

MEC Q4 2025 earnings call: data center growth pipeline tops $125M, margins pressured by launch costs, and new 2026 guidance.

AI turns power and cooling into one big puzzle, but using a digital twin makes it easy to solve, check and manage everything without the usual guesswork.

Synthetic full backups became the newest way to backup without actually moving all of your data. Backup software or API-based ...

Staying resilient in 2026 will require leaders to reassess how they define risk, prioritize investments and measure readiness across the enterprise.

In this weekly Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve ...